Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Fleshner

Showing results (101-110 of 266) with videos related to

Pageof 27
Sort By:
Nutrition and Cancer|June 25, 2010
Antiproliferative mechanisms of the flavonoids 2,2'-dihydroxychalcone and fisetin in human prostate cancer cellsAhmed Q Haddad, Neil Fleshner, Colleen Nelson, et al.
Urology|July 15, 2019
Lynch Syndrome in Urologic Malignancies - What Does the Urologist Need to Know?Hanan Goldberg, Christopher J D Wallis, Zachary Klaassen, et al.
The Journal of Urology|September 19, 2009
Transperitoneal laparoscopic prostatectomy does not increase small bowel within the target volume for postoperative radiotherapyAntonio Finelli, Sanoj Punnen, Tara Rosewall, et al.
The Journal of Urology|February 26, 2020
Testosterone Breakthrough Rates during Androgen Deprivation Therapy for Castration Sensitive Prostate CancerFred Saad, Neil Fleshner, Tom Pickles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2013
Altered DNA methylation landscapes of polycomb-repressed loci are associated with prostate cancer progression and ERG oncogene expression in prostate cancerKen Kron, Dominique Trudel, Vaijayanti Pethe, et al.
The Prostate|December 8, 2021
Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic diseaseChristopher Ma, Michelle Downes, Rahi Jain, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 8, 2022
Impact of cribriform pattern 4 and intraductal prostatic carcinoma on National Comprehensive Cancer Network (NCCN) and Cancer of Prostate Risk Assessment (CAPRA) patient stratificationYanhong Yu, Katherine Lajkosz, Antonio Finelli, et al.
World Journal of Urology|February 17, 2017
Androgen deprivation therapy and the risk of parkinsonism in men with prostate cancerJames W S Young, Rinku Sutradhar, Jagadish Rangrej, et al.
Clinical Breast Cancer|December 17, 2008
A BRCA1 mutation is not associated with increased indicators of oxidative stressJoanne Kotsopoulos, HongLei Shen, A Venketeshwer Rao, et al.
Prostate Cancer and Prostatic Diseases|December 16, 2017
Total energy expenditure and vigorous-intensity physical activity are associated with reduced odds of reclassification among men on active surveillanceDavid E Guy, Avi Vandersluis, Laurence H Klotz, et al.
Pageof 27

Showing results (101-110 of 266) with videos related to

Sort By:
Pageof 27
Nutrition and Cancer|June 25, 2010
Antiproliferative mechanisms of the flavonoids 2,2'-dihydroxychalcone and fisetin in human prostate cancer cellsAhmed Q Haddad, Neil Fleshner, Colleen Nelson, et al.
Urology|July 15, 2019
Lynch Syndrome in Urologic Malignancies - What Does the Urologist Need to Know?Hanan Goldberg, Christopher J D Wallis, Zachary Klaassen, et al.
The Journal of Urology|September 19, 2009
Transperitoneal laparoscopic prostatectomy does not increase small bowel within the target volume for postoperative radiotherapyAntonio Finelli, Sanoj Punnen, Tara Rosewall, et al.
The Journal of Urology|February 26, 2020
Testosterone Breakthrough Rates during Androgen Deprivation Therapy for Castration Sensitive Prostate CancerFred Saad, Neil Fleshner, Tom Pickles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2013
Altered DNA methylation landscapes of polycomb-repressed loci are associated with prostate cancer progression and ERG oncogene expression in prostate cancerKen Kron, Dominique Trudel, Vaijayanti Pethe, et al.
The Prostate|December 8, 2021
Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic diseaseChristopher Ma, Michelle Downes, Rahi Jain, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 8, 2022
Impact of cribriform pattern 4 and intraductal prostatic carcinoma on National Comprehensive Cancer Network (NCCN) and Cancer of Prostate Risk Assessment (CAPRA) patient stratificationYanhong Yu, Katherine Lajkosz, Antonio Finelli, et al.
World Journal of Urology|February 17, 2017
Androgen deprivation therapy and the risk of parkinsonism in men with prostate cancerJames W S Young, Rinku Sutradhar, Jagadish Rangrej, et al.
Clinical Breast Cancer|December 17, 2008
A BRCA1 mutation is not associated with increased indicators of oxidative stressJoanne Kotsopoulos, HongLei Shen, A Venketeshwer Rao, et al.
Prostate Cancer and Prostatic Diseases|December 16, 2017
Total energy expenditure and vigorous-intensity physical activity are associated with reduced odds of reclassification among men on active surveillanceDavid E Guy, Avi Vandersluis, Laurence H Klotz, et al.
Pageof 27